A clinical retrospective study carried out by Zheng Y et al [14] demonstrated that the sequence of first-line pemetrexed followed by icotinib is promising for advanced lung cancer harboring unknown EGFR gene in China. This evidence concerns the gene EGFR and lung cancer.